18th Sep 2013 14:11
18 September 2013
Dechra® Pharmaceuticals PLC
("Dechra" or "the Company")
Additional Listing
An application has been made to the Financial Conduct Authority and the London Stock Exchange for admission to (i) the Official List and (ii) to trading on the London Stock Exchange's markets for a block admission of securities in respect of 211,000 ordinary shares of 1 pence each (the "Shares").
These Shares are being reserved under a block listing and will be issued pursuant to the following schemes:
Scheme | Shares |
SAYE Scheme | 120,000 |
Approved Share Option Scheme | 31,000 |
Unapproved Share Option Scheme | 60,000 |
These Shares will rank pari passu with the Company's existing shares in issue. It is expected that admission will become effective on 23 September 2013.
For further information, please contact:
Zoe Goulding, Company Secretary
Telephone number: 01606 814730
About Dechra
Dechra is an international specialist veterinary pharmaceuticals business. Its expertise is in the development, manufacturing and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. For more information please visit: www.dechra.com
Trademarks
Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.
Related Shares:
DPH.L